The latest price target for Verastem (NASDAQ:VSTM) was reported by RBC Capital on July 7, 2026. The analyst firm set a price target for $14.00 expecting VSTM to rise to within 12 months (a possible 138.10% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Verastem (NASDAQ:VSTM) was provided by RBC Capital, and Verastem maintained their outperform rating.

There is no last upgrade for Verastem

There is no last downgrade for Verastem.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verastem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verastem was filed on July 7, 2026 so you should expect the next rating to be made available sometime around July 7, 2027.

While ratings are subjective and will change, the latest Verastem (VSTM) rating was a maintained with a price target of $15.00 to $14.00. The current price Verastem (VSTM) is trading at is $5.88, which is out of the analyst’s predicted range.